-
A Shared Path Toward Cancer ProgressThe AACR Scientist↔Survivor Program equips advocates with the scientific knowledge to share new research with patients in their own communities.
by Darlene Dobkowski
-
Can People With Oral Lesions Avoid Surgery?Injecting immunotherapy directly into precancerous lesions in the mouth can shrink precancerous lesions.
by Eric Fitzsimmons
-
Wildfire Smoke Exposure Linked to Increased Cancer RiskPeople exposed to high levels of airborne particles from wildfire smoke were more likely to be diagnosed with five cancer types.
by Eric Fitzsimmons
-
Plant-forward Diet Linked to Lower Risk for Aggressive Breast Cancer SubtypeWomen who ate a diet focused on both human health and sustainability had reduced risk for estrogen receptor-negative disease.
by Thomas Celona
-
CAR T-cell Therapy Prevents Progression in High-risk Smoldering MyelomaEarly study suggests an immunotherapy can eliminate precancerous cells in people with high-risk disease.
by Darlene Dobkowski
-
Aromatase Inhibitor Use Linked to Blood Pressure, Diabetes RiskPeople who took aromatase inhibitors to prevent breast cancer recurrence for at least five years had a higher risk of developing cardiometabolic conditions.
by Eric Fitzsimmons
-
Hypothyroidism Is Associated With Increased Survival in Some CancersSome cancer survivors develop hypothyroidism as a result of cancer treatment. Research shows this side effect is linked to prolonged survival in some cancer types.
by Darlene Dobkowski
-
Forward Look
Targeted Therapy Prompts Responses in KRAS-mutated Lung CancerAn experimental KRAS inhibitor controls lung cancer after other targeted treatments stop working.
by Eric Fitzsimmons
-
Wearable Devices Help Monitor Patient Health After Cancer TreatmentResearchers evaluate whether devices that track health metrics like daily steps and heart rate can help predict clinical outcomes.
by Darlene Dobkowski
-
Safely Extending Treatment in Alveolar Soft Part SarcomaPeople with the soft tissue cancer can receive immunotherapy for an extended period without long-term side effects.
by Thomas Celona
When doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
Does Exercise Benefit Children With Cancer?New guidelines recommend children and adolescents with cancer get regular physical activity to mitigate side effects from treatment.
by Erin O’Donnell
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
